Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Capitalization 1.11B 8.62B 84.53B P/E ratio 2024 *
-5.97x
P/E ratio 2025 * -7.86x
Enterprise value 1.43B 11.15B 109B EV / Sales 2024 *
1.24x
EV / Sales 2025 * 0.86x
Free-Float
51.5%
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.86%
1 week-4.86%
Current month-4.86%
1 month-11.15%
3 months-22.31%
6 months-30.47%
Current year-44.18%
More quotes
1 week
4.48
Extreme 4.48
4.89
1 month
4.46
Extreme 4.46
5.32
Current year
4.46
Extreme 4.46
8.52
1 year
4.46
Extreme 4.46
14.24
3 years
4.46
Extreme 4.46
52.75
5 years
4.46
Extreme 4.46
72.85
10 years
2.63
Extreme 2.63
72.85
More quotes
Director TitleAgeSince
Chief Executive Officer 61 30/04/98
Director of Finance/CFO 48 21/07/10
Chief Operating Officer 67 31/12/16
Manager TitleAgeSince
Director/Board Member 70 31/10/06
Director/Board Member 60 02/09/10
Chief Executive Officer 61 30/04/98
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.86%-4.86%-62.22%-90.34%1.1B
+1.65%+2.53%+20.74%+9.31%234B
+2.07%+2.93%+8.72%-17.18%192B
+1.09%-1.30%+57.82%+33.79%168B
+1.02%+1.73%+51.28%+81.77%120B
-0.87%-4.24%+10.69%-12.57%62.62B
-0.66%-4.10%-7.41%-27.77%41.31B
-1.20%-3.83%-11.69%-45.84%40.25B
+0.55%-0.65%+22.06%-22.11%39.42B
+0.35%+0.77%+28.26% - 38.86B
Average +0.52%-2.17%+11.83%-10.10% 93.72B
Weighted average by Cap. +1.10%-1.90%+25.79%+10.70%
See all sector performances

Financials

2024 *2025 *
Net sales 1.15B 8.96B 87.87B 1.35B 10.49B 103B
Net income -186M -1.45B -14.2B -155M -1.2B -11.81B
Net Debt 323M 2.52B 24.72B 49.07M 383M 3.75B
More financial data * Estimated data
Logo MicroPort Scientific Corporation
MicroPort Scientific Corporation is a Hong Kong-based investment holding company principally engaged in the manufacture and sales of medical products. The Company operates through seven segments. Orthopedics Devices segment researches, develops, manufactures and sells orthopedics devices. Cardiovascular Devices segment researches, develops, manufactures and sells cardiovascular devices, such as drug eluting stents. Endovascular Devices segment researches, develops, manufactures and sells endovascular devices. Electrophysiology Devices segment researches, develops, manufactures and sells electrophysiology devices. Neurovascular Devices segment researches, develops, manufactures and sells neurovascular devices. Surgical Management segment researches, develops, manufactures and sells surgical devices. Diabetes Care and Endocrinal Management segment researches, develops, manufactures and sells devices related to diabetes mellitus.
Employees
6,987
More about the company
Date Price Change Volume
09/09/24 4.700 $ +0.86% 7,069,000
05/09/24 4.660 $ +1.30% 3,192,000
04/09/24 4.600 $ -2.54% 5,427,600
03/09/24 4.720 $ -0.63% 4,067,500
02/09/24 4.750 $ -3.85% 5,342,714

Delayed Quote Hong Kong S.E., September 09, 2024 at 09:08 am

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
0.6028USD
Average target price
1.424USD
Spread / Average Target
+136.25%
Consensus

Annual profits - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW